Albany Molecular Research Inc (Nasdaq: AMRI) on Tuesday said it expects the acquisition of Gadea Pharmaceutical to add over 50% to its full year contract revenu 15 September 2015
Netherlands-incorporated generic drugmaker Mylan (Nasdaq: MYL) has officially initiated its hostile takeover bid for Ireland-based Perrigo, following public rej 15 September 2015
Indian drugmaker Cipla has entered into definitive agreements to acquire two USA-based companies, InvaGen Pharmaceuticals and Exelan Pharmaceutics. 4 September 2015
Generic drug company Alvogen said it has agreed to buy a portfolio of four pharmaceutical products, in the US from pharma giant Pfizer (NYSE: PFE) in a bid to f 27 August 2015
Netherlands-incorporated Mylan (Nasdaq: MYL) said it now needs just over 50% shares in hostile takeover target Perrigo (NYSE: PRGO) to control the company. 14 August 2015
Israel-based Teva Pharmaceutical Industries (NYSE.TEVA) is well positioned to make a substantial return on investment from the acquisition of Allergan’s (NYSE.A 30 July 2015
Generics specialist Mylan has moved to block a hostile takeover bid by Israeli company Teva by setting up an independent Dutch foundation which has exercised it 24 July 2015
According to sources close to the matter, Israel-based Teva Pharmaceutical Industries is considering upping its offer to buy US generic drugmaker Mylan (Nasdaq: 7 July 2015
Indian drugmaker Cadila Healthcare is nearing a deal to buy the generic sterile injectables business of rival Claris Lifesciences, according so sources close to 22 May 2015